Brief: Anixa Biosciences' Covid-19 Compounds Expected To Be Effective Against The Delta Variant
25/08/2021 13:59
Aug 25 (Reuters) - Anixa Biosciences Inc ANIX.O :
* ANIXA BIOSCIENCES' COVID-19 COMPOUNDS EXPECTED TO BE
EFFECTIVE
AGAINST THE DELTA VARIANT
Source text for Eikon: ID:nPn4PJ5QZa
Further company coverage: ANIX.O
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine